“Blue light blocking glasses reduce digital eye strain and protect the retina”

Two claims ride together on the box, and they fail in different ways: eye strain has been tested and the lenses did not help, while retinal protection has never been tested in people at all.

The strongest evidence is a 2023 Cochrane review. Cochrane is an independent research network that gathers every randomised controlled trial run on a question - a trial being a study where people are assigned by chance to the filtering lenses or to ordinary clear ones, so the two groups are otherwise alike. It found 17 trials in adults, 5 to 156 people each, with the lenses worn for anywhere between a single day and five weeks [1].

Three of those trials scored eye strain symptoms, and none found an improvement over ordinary lenses [1]. Sharpness of vision did not shift either: in the one trial of 156 people that measured it, the difference between the two lens types was zero [1].

The retina half of the claim is a blank page rather than a negative result. Cochrane reported no trial evidence at all on the health of the macula, the central part of the retina used for sharp vision [1]. An earlier systematic review of 3 trials in 136 adults hit the same dead end and said it found no studies of macular structure or function [2]. The retina-protection story comes from laboratory work on cells and animals, and nobody has carried it into a human trial.

Sleep is the one outcome where the answer is genuinely unsettled. Six trials covering 148 adults measured sleep quality: three reported better sleep with the filtering lenses and three reported no difference [1]. Cochrane's own summary calls that evidence too weak to draw a conclusion from. An earlier trial found a small improvement only among people who already reported insomnia [2].

What the evidence does point at is everything except the lens. A 2023 report from the Tear Film and Ocular Surface Society, the largest review of screens and the eye's surface, puts digital eye strain down to blinking less often and less completely while staring at a screen, to prescriptions that are wrong or missing for the distance the screen actually sits at, to undiagnosed problems with the two eyes working together, and to the brightness, glare and position of the display [3]. It states plainly that blue-light-blocking is not an effective way to manage the condition [3].

The evidence has limits worth naming:

• the trials were small and short, five weeks at the outside, so none of this speaks to decades of screen use
• most left out people who already have eye disease
• Cochrane graded the eye strain evidence as weak and would not combine the trials into a single number, because they measured different things in different groups of people
• the lenses were always compared against ordinary clear lenses, never against wearing nothing

Side effects were logged inconsistently. Across the nine trials covering 333 people that reported them, the problems noted with blue-light-filtering lenses were headache, discomfort wearing the glasses, lower mood and increased depressive symptoms - all infrequent, and the clear lenses drew similar complaints [1].

So the claim is debunked on the half that has been tested, and unproven on the half that has not. For an adult doing ordinary computer work, the digital eye strain benefit is one no trial has found, and the retina benefit is one nobody has measured.